Two-Front fight: powerful chemo tested to wipe out rectal cancer and liver tumors
NCT ID NCT07467434
Summary
This study aims to find the best way to treat people with rectal cancer that has also spread to the liver. It will follow 550 patients who first receive a strong chemotherapy regimen called FOLFIRINOX. The main goal is to see how many patients can later have successful surgery to remove all cancer from both the rectum and the liver.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Digestive Surgery Department, Bicêtre University Hospital AP-HP
Le Kremlin-Bicêtre, 94270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.